Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Millward

Showing results (181-190 of 224) with videos related to

Pageof 23
Sort By:
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|September 16, 2011
A phase II study of AT-101 (Gossypol) in chemotherapy-sensitive recurrent extensive-stage small cell lung cancerMaria Q Baggstrom, Yingwei Qi, Marianna Koczywas, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 22, 2000
Optimizing the erythromycin breath test for use in cancer patientsL P Rivory, K Slaviero, J P Seale, et al.
European Journal of Cancer (Oxford, England : 1990)|December 1, 1995
Phase I and pharmacokinetic study of a water-soluble etoposide prodrug, etoposide phosphate (BMY-40481)M J Millward, D R Newell, V Mummaneni, et al.
Cancer Chemotherapy and Pharmacology|May 17, 2003
Phase I trial of fixed dose-rate gemcitabine in combination with carboplatin in chemonaive advanced non-small-cell lung cancer: a Cancer Therapeutics Research Group studyRoss A Soo, Hong L Lim, Ling Z Wang, et al.
Expert Review of Anticancer Therapy|January 29, 2021
A phase 1b clinical trial optimizing regulatory T cell depletion in combination with platinum-based chemotherapy in thoracic cancersAlistair M Cook, Alison McDonnell, Michael J Millward, et al.
Seminars in Oncology|October 1, 1994
Carboplatin and granulocyte colony-stimulating factor as first-line treatment for epithelial ovarian cancer: a phase I dose-intensity escalation studyA H Calvert, M J Lind, S Ghazal-Aswad, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|May 20, 2015
Human CD45RA(-) FoxP3(hi) Memory-Type Regulatory T Cells Show Distinct TCR Repertoires With Conventional T Cells and Play an Important Role in Controlling Early Immune ActivationH Lei, L Kuchenbecker, M Streitz, et al.
Osteoarthritis and Cartilage|August 8, 2006
Differential cartilaginous tissue formation by human synovial membrane, fat pad, meniscus cells and articular chondrocytesA Marsano, S J Millward-Sadler, D M Salter, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 1, 1996
Phase II trial of a 3-hour infusion of paclitaxel in previously untreated patients with advanced non-small-cell lung cancerM J Millward, J F Bishop, M Friedlander, et al.
The Permanente Journal|August 20, 2016
Amniotic Fluid Embolism: Using the Medical Staff Process to Facilitate Streamlined CarePeter M Hession, Cynthia J Millward, Joyce E Gottesfeld, et al.
Pageof 23

Showing results (181-190 of 224) with videos related to

Sort By:
Pageof 23
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|September 16, 2011
A phase II study of AT-101 (Gossypol) in chemotherapy-sensitive recurrent extensive-stage small cell lung cancerMaria Q Baggstrom, Yingwei Qi, Marianna Koczywas, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 22, 2000
Optimizing the erythromycin breath test for use in cancer patientsL P Rivory, K Slaviero, J P Seale, et al.
European Journal of Cancer (Oxford, England : 1990)|December 1, 1995
Phase I and pharmacokinetic study of a water-soluble etoposide prodrug, etoposide phosphate (BMY-40481)M J Millward, D R Newell, V Mummaneni, et al.
Cancer Chemotherapy and Pharmacology|May 17, 2003
Phase I trial of fixed dose-rate gemcitabine in combination with carboplatin in chemonaive advanced non-small-cell lung cancer: a Cancer Therapeutics Research Group studyRoss A Soo, Hong L Lim, Ling Z Wang, et al.
Expert Review of Anticancer Therapy|January 29, 2021
A phase 1b clinical trial optimizing regulatory T cell depletion in combination with platinum-based chemotherapy in thoracic cancersAlistair M Cook, Alison McDonnell, Michael J Millward, et al.
Seminars in Oncology|October 1, 1994
Carboplatin and granulocyte colony-stimulating factor as first-line treatment for epithelial ovarian cancer: a phase I dose-intensity escalation studyA H Calvert, M J Lind, S Ghazal-Aswad, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|May 20, 2015
Human CD45RA(-) FoxP3(hi) Memory-Type Regulatory T Cells Show Distinct TCR Repertoires With Conventional T Cells and Play an Important Role in Controlling Early Immune ActivationH Lei, L Kuchenbecker, M Streitz, et al.
Osteoarthritis and Cartilage|August 8, 2006
Differential cartilaginous tissue formation by human synovial membrane, fat pad, meniscus cells and articular chondrocytesA Marsano, S J Millward-Sadler, D M Salter, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 1, 1996
Phase II trial of a 3-hour infusion of paclitaxel in previously untreated patients with advanced non-small-cell lung cancerM J Millward, J F Bishop, M Friedlander, et al.
The Permanente Journal|August 20, 2016
Amniotic Fluid Embolism: Using the Medical Staff Process to Facilitate Streamlined CarePeter M Hession, Cynthia J Millward, Joyce E Gottesfeld, et al.
Pageof 23